203 related articles for article (PubMed ID: 23685488)
1. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine.
Ulviye Y; Betul T; Nur TH; Selda C
Indian J Ophthalmol; 2013 Apr; 61(4):168-71. PubMed ID: 23685488
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
3. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
Stepien KE; Han DP; Schell J; Godara P; Rha J; Carroll J
Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
[TBL] [Abstract][Full Text] [Related]
4. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity.
Pasadhika S; Fishman GA; Choi D; Shahidi M
Eye (Lond); 2010 May; 24(5):756-62; quiz 763. PubMed ID: 20395978
[TBL] [Abstract][Full Text] [Related]
5. Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.
Kan E; Yakar K; Demirag MD; Gok M
Int Ophthalmol; 2018 Aug; 38(4):1635-1640. PubMed ID: 28695378
[TBL] [Abstract][Full Text] [Related]
6. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
[TBL] [Abstract][Full Text] [Related]
7. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
8. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
9. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT.
Yülek F; Uğurlu N; Akçay E; Kocamış Sİ; Gerçeker S; Erten Ş; Midillioğlu İ; Şimşek Ş
Cutan Ocul Toxicol; 2013 Sep; 32(3):204-9. PubMed ID: 23351071
[TBL] [Abstract][Full Text] [Related]
10. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
11. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
[TBL] [Abstract][Full Text] [Related]
12. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
13. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
[TBL] [Abstract][Full Text] [Related]
14. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
[TBL] [Abstract][Full Text] [Related]
15. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
[TBL] [Abstract][Full Text] [Related]
16. Macula pigment optical densitometry changes in hydroxychloroquine use.
Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
[TBL] [Abstract][Full Text] [Related]
17. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
18. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
19. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy.
Kelmenson AT; Brar VS; Murthy RK; Chalam KV
Eur J Ophthalmol; 2010; 20(4):785-8. PubMed ID: 20099229
[TBL] [Abstract][Full Text] [Related]
20. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]